Patient Disease:

Canine Glioma

Study Name:

Canine Brain Tumor Vaccine Clinical Trial

Purpose of the study:

  • Evaluation of preliminary tumor response to vaccine that targets cancer stem cells as well as vaccine tolerability

Primary Eligibility Criteria:

  • Dogs with glioma type tumors based on MRI characteristics
  • Patients must still be in overall good health and stable condition
  • Not dependent on prednisone to control clinical signs
  • Seizures (if occurring) must be controlled with anti-convulsant medication
  • Measureable disease present and visible on MRI
  • Pets must come to CSU for all visits related to the clinical trial

Study Protocol:

  • Pre-enrollment screening: physical/neurological exam, blood tests, MRI of the brain
  • Needle biopsy to confirm glioma diagnosis
  • Treatment of tumor with stereotactic radiotherapy (SRT)
  • Vaccination, physical exam, study blood sampling every other week for 6 treatments then monthly boosters
  • Follow up MRI scans at 6th vaccine treatment and then every 3 months

Owner Responsibilities:

  • You are responsible for initial screening tests (consultation/physical exam, blood and urine tests, MRI of brain)
  • You are expected to make and keep all appointments associated with the study

Financial Incentives:

  • Study will pay for all costs associated with the biopsy and SRT at the initial visit
  • All study medications will be covered
  • The study will pay for every other recheck MRI
  • Recheck MRIs that will be owner’s responsibility will be discounted 50%
  • Adverse events directly associated with the vaccine will be covered by the study
  • In the event of the patient’s death, necropsy and private cremation will be covered by the study

If you have further questions about this clinical trial, please email or call (970) 297-4405.